Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elgene Lim

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Melanoma Research|July 18, 2006
Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigensElgene Lim, Judy Browning, Duncan MacGregor, et al.
Endocrine-Related Cancer|February 15, 2017
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapyAndrew M K Law, Elgene Lim, Christopher J Ormandy, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2017
Attitudes of patients with metastatic cancer towards research biopsiesDanielle H Robinson, Leonid Churilov, Nancy U Lin, et al.
Cancer Metastasis Reviews|November 24, 2016
EMT, cell plasticity and metastasisChristine L Chaffer, Beatriz P San Juan, Elgene Lim, et al.
Molecular & Cellular Oncology|December 7, 2017
Sensitizing HR-proficient cancers to PARP inhibitorsElgene Lim, Shawn F Johnson, Matthias Geyer, et al.
Current Breast Cancer Reports|May 27, 2014
Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed TherapyElgene Lim, Min Ni, Shiliang Cao, et al.
Frontiers in Oncology|February 10, 2016
Clinical Overview of MDM2/X-Targeted TherapiesAndrew Burgess, Kee Ming Chia, Sue Haupt, et al.
Journal of Molecular Cell Biology|January 19, 2017
The role of MDM2 and MDM4 in breast cancer development and preventionSue Haupt, Reshma Vijayakumaran, Panimaya Jeffreena Miranda, et al.
Endocrine-Related Cancer|November 4, 2018
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancerNeil Portman, Sarah Alexandrou, Emma Carson, et al.
Cancers|February 15, 2022
Epigenetic Therapies and Biomarkers in Breast CancerLauren Julia Brown, Joanna Achinger-Kawecka, Neil Portman, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Melanoma Research|July 18, 2006
Desmoplastic melanoma: comparison of expression of differentiation antigens and cancer testis antigensElgene Lim, Judy Browning, Duncan MacGregor, et al.
Endocrine-Related Cancer|February 15, 2017
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapyAndrew M K Law, Elgene Lim, Christopher J Ormandy, et al.
Asia-Pacific Journal of Clinical Oncology|November 7, 2017
Attitudes of patients with metastatic cancer towards research biopsiesDanielle H Robinson, Leonid Churilov, Nancy U Lin, et al.
Cancer Metastasis Reviews|November 24, 2016
EMT, cell plasticity and metastasisChristine L Chaffer, Beatriz P San Juan, Elgene Lim, et al.
Molecular & Cellular Oncology|December 7, 2017
Sensitizing HR-proficient cancers to PARP inhibitorsElgene Lim, Shawn F Johnson, Matthias Geyer, et al.
Current Breast Cancer Reports|May 27, 2014
Importance of Breast Cancer Subtype in the Development of Androgen Receptor Directed TherapyElgene Lim, Min Ni, Shiliang Cao, et al.
Frontiers in Oncology|February 10, 2016
Clinical Overview of MDM2/X-Targeted TherapiesAndrew Burgess, Kee Ming Chia, Sue Haupt, et al.
Journal of Molecular Cell Biology|January 19, 2017
The role of MDM2 and MDM4 in breast cancer development and preventionSue Haupt, Reshma Vijayakumaran, Panimaya Jeffreena Miranda, et al.
Endocrine-Related Cancer|November 4, 2018
Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancerNeil Portman, Sarah Alexandrou, Emma Carson, et al.
Cancers|February 15, 2022
Epigenetic Therapies and Biomarkers in Breast CancerLauren Julia Brown, Joanna Achinger-Kawecka, Neil Portman, et al.
Pageof 13